Court Favors Boehringer In Third Pradaxa Bellwether Trial
Court Favors Boehringer In Third Pradaxa Bellwether Trial
Introduction
A Hartford Superior Court ruled in favor of Boehringer Ingelheim Pharmaceuticals in the third bellwether trial involving claims by a man who suffered bleeding due to the alleged use of blood thinner medication Pradaxa.
The trial for claims brought by the plaintiff in 2016 concluded after a three-week deliberation, and it is the third straight win for Boehringer. The first two trials held in March 2018 and May 2018 also ended in a defense verdict. The next bellwether trial involving claims of health hazards of Pradaxa will begin in February 2019.
Pradaxa was initially approved by the U.S. FDA to be used as a blood thinner, but reports suggest it causes serious injuries and gastrointestinal bleeding, heart attack, stroke, brain hemorrhage, kidney bleeding, and death. Judge Herndon, who overlooked Pradaxa class action lawsuits, recommended a shutdown of the multidistrict litigation (MDL No. 2385) in December 2017 after dismissing pending cases in the docket.
Comments
Latest News
Oregon to Get $66M in Sackler Opioid Settlement
Categories: Opioids
Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…
Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors
Categories: E-Cigarette: JUUL
As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.
A study published in Environmental Health Perspectives in…
Appeals Court Upholds $611M Roundup Verdict
Categories: Roundup
A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.
The case involved three plaintiffs from New…